Breaking
Thursday, July 9, 2026

News

🇺🇸 FDA Page 66

Latest pharmaceutical news, drug approvals, and FDA regulatory updates

Showing 781–792 of 807 articles

High impact NewsApr 4, 2026

FDA Approves Repatha for Pediatric Heterozygous Familial Hypercholesterolemia

FDA · cardiology · 4 min

Dr. Sarah Mitchell
High impact NewsApr 4, 2026

FDA Approves Adzynma: New Treatment for Thrombotic Thrombocytopenic Purpura

FDA · Hematology · 6 min

Dr. Sarah Mitchell
High impact NewsApr 4, 2026

FDA Approves First OTC Naloxone Nasal Spray for Opioid Overdose

FDA · Opioid Overdose Treatment · 5 min

Dr. Sarah Mitchell
High impact NewsApr 4, 2026

FDA Grants Priority Review to Sotorasib for KRAS G12C NSCLC

FDA · non-small cell lung cancer · 4 min

Dr. Sarah Mitchell
High impact NewsApr 4, 2026

FDA Approves Veozah: New Non-Hormonal Menopause Treatment

FDA · Menopause · 4 min

Dr. Sarah Mitchell
High impact NewsApr 3, 2026

FDA Approves Omisirge: New Allogeneic Stem Cell Therapy for Hematologic Cancers

FDA · hematologic malignancies · 4 min

Dr. Sarah Mitchell
High impact NewsApr 3, 2026

FDA Approves Updated COVID-19 Vaccines for Fall 2024

FDA · Infectious Disease · 4 min

Dr. Sarah Mitchell
High impact NewsApr 3, 2026

FDA Approves Bosulif for Pediatric Chronic Myelogenous Leukemia

FDA · chronic myelogenous leukemia · 7 min

Dr. Sarah Mitchell
High impact NewsApr 3, 2026

FDA Approves Ztalmy: First Therapy for CDKL5 Deficiency Seizures

FDA · neurology · 4 min

Dr. Sarah Mitchell
High impact NewsApr 2, 2026

FDA Approves Opdivo Plus Chemotherapy for Gastric Cancer

FDA · gastric cancer · 4 min

Dr. Sarah Mitchell
High impact NewsApr 2, 2026

FDA Approves Breyanzi: Novel CAR-T Therapy for Mantle Cell Lymphoma

FDA · mantle cell lymphoma · 4 min

Dr. Sarah Mitchell
High impact NewsApr 2, 2026

FDA Approval Mirvetuximab Soravtansine: Accelerated OK for Elahere in Ovarian Cancer

FDA · Ovarian Cancer · 4 min

Dr. Sarah Mitchell